Ignite Creation Date:
2024-05-06 @ 3:07 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04520373
Status:
RECRUITING
Last Update Posted:
2023-09-08
First Post:
2020-07-14
Brief Title:
Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
CELLTOP Part II A Phase II Clinical Trial of Autologous Adipose Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research study is to investigate the safety and potential therapeutic effects of autologous culture-expanded adipose derived mesenchymal stem cell intrathecal injections in the treatment of spinal cord injury
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None